Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
2020
Marina Nishida, and
Takuya Takeichi, and
Michihiro Kono, and
Akiko Imanishi, and
Naoki Maekawa, and
Masashi Akiyama, and
Kazuyoshi Fukai
Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
UI
MeSH Term
Description
Entries
D008297
Male
Males
D011565
Psoriasis
A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002648
Child
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.
Children
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867
Skin
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D061067
Antibodies, Monoclonal, Humanized
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Antibodies, Humanized,Humanized Antibodies
Related Publications
Marina Nishida, and
Takuya Takeichi, and
Michihiro Kono, and
Akiko Imanishi, and
Naoki Maekawa, and
Masashi Akiyama, and
Kazuyoshi Fukai